Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials.
Bloom D, Beetsch J, Harker M, Hesterlee S, Moreira P, Patrick-Lake B, Selig W, Sherman J, Smith SK, Valentine JE, Roberts JN. Bloom D, et al. Among authors: selig w. Ther Innov Regul Sci. 2018 Mar;52(2):206-213. doi: 10.1177/2168479017720247. Epub 2017 Jul 27. Ther Innov Regul Sci. 2018. PMID: 29714514 Free PMC article.
Leveraging Patient Preference Information in Medical Device Clinical Trial Design.
Rincon-Gonzalez L, Selig WKD, Hauber B, Reed SD, Tarver ME, Chaudhuri SE, Lo AW, Bruhn-Ding D, Liden B. Rincon-Gonzalez L, et al. Among authors: selig wkd. Ther Innov Regul Sci. 2023 Jan;57(1):152-159. doi: 10.1007/s43441-022-00450-9. Epub 2022 Aug 27. Ther Innov Regul Sci. 2023. PMID: 36030334 Free PMC article.
The promise of Immuno-oncology: implications for defining the value of cancer treatment.
Kaufman HL, Atkins MB, Subedi P, Wu J, Chambers J, Joseph Mattingly T 2nd, Campbell JD, Allen J, Ferris AE, Schilsky RL, Danielson D, Lichtenfeld JL, House L, Selig WKD. Kaufman HL, et al. Among authors: selig wkd. J Immunother Cancer. 2019 May 17;7(1):129. doi: 10.1186/s40425-019-0594-0. J Immunother Cancer. 2019. PMID: 31101066 Free PMC article.
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, Mellinghoff IK, Weller M, Chang S, Arons D, Meehan C, Selig W, Tanner K, Alfred Yung WK, van den Bent M, Wen PY, Cloughesy TF. Ellingson BM, et al. Among authors: selig w. Neuro Oncol. 2022 Aug 1;24(8):1219-1229. doi: 10.1093/neuonc/noac086. Neuro Oncol. 2022. PMID: 35380705 Free PMC article.
Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
Forde PM, Bonomi P, Shaw A, Blumenthal GM, Ferris A, Patel C, Melemed A, Basu Roy U, Ramamoorthy A, Liu Q, Burns T, Gainor JF, Lovly C, Piotrowska Z, Lehman J, Selig W. Forde PM, et al. Among authors: selig w. Clin Lung Cancer. 2020 Jul;21(4):295-307. doi: 10.1016/j.cllc.2020.02.008. Epub 2020 Feb 26. Clin Lung Cancer. 2020. PMID: 32201247
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
Lee EQ, Selig W, Meehan C, Bacha J, Barone A, Bloomquist E, Chang SM, de Groot JF, Galanis E, Hassan I, Kalidas C, Khasraw M, Kvedar JC, Lassman AB, Puduvalli V, Sahebjam S, Schwamm LH, Tamir S, Welch M, Yung WKA, Zadeh G, Arons D, Wen PY. Lee EQ, et al. Among authors: selig w. Neuro Oncol. 2021 Aug 2;23(8):1252-1260. doi: 10.1093/neuonc/noab082. Neuro Oncol. 2021. PMID: 33822177 Free PMC article.
67 results